Pages that link to "Q34115362"
Jump to navigation
Jump to search
The following pages link to Abnormal breath testing in IBS: a meta-analysis (Q34115362):
Displaying 50 items.
- Use of rifaximin in gastrointestinal and liver diseases (Q26740201) (← links)
- Relationships among the lactulose breath test, intestinal gas volume, and gastrointestinal symptoms in patients with irritable bowel syndrome. (Q33449179) (← links)
- Rifaximin treatment for the irritable bowel syndrome with a positive lactulose hydrogen breath test improves symptoms for at least 3 months (Q33456102) (← links)
- Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome: A Bridge between Functional Organic Dichotomy (Q33469991) (← links)
- Inflammation and Microflora (Q33824492) (← links)
- The prevalence of overgrowth by aerobic bacteria in the small intestine by small bowel culture: relationship with irritable bowel syndrome (Q34248518) (← links)
- Comparison of the antibacterial activity of essential oils and extracts of medicinal and culinary herbs to investigate potential new treatments for irritable bowel syndrome. (Q34454007) (← links)
- Is the Intestinal Gas Associated With the Development of Right Colonic Diverticula? (Q34588737) (← links)
- Restless legs syndrome is associated with irritable bowel syndrome and small intestinal bacterial overgrowth (Q34629149) (← links)
- Antibiotics for irritable bowel syndrome: rationale and current evidence (Q34642080) (← links)
- Mechanisms and effectiveness of prebiotics in modifying the gastrointestinal microbiota for the management of digestive disorders (Q34726491) (← links)
- Gas and the microbiome (Q35024458) (← links)
- Evidence-based clinical practice guidelines for irritable bowel syndrome. (Q35513973) (← links)
- Molecular assessment of differences in the duodenal microbiome in subjects with irritable bowel syndrome. (Q35599906) (← links)
- Development and validation of a biomarker for diarrhea-predominant irritable bowel syndrome in human subjects (Q35603014) (← links)
- Antibiotics for the treatment of irritable bowel syndrome (Q35691133) (← links)
- Review article: potential mechanisms of action of rifaximin in the management of irritable bowel syndrome with diarrhoea (Q35855740) (← links)
- Small intestinal bacterial overgrowth is associated with irritable bowel syndrome and is independent of proton pump inhibitor usage (Q36073385) (← links)
- Antibiotics as deep modulators of gut microbiota: between good and evil. (Q36105508) (← links)
- Small Intestinal Bacterial Overgrowth in Patients with Refractory Functional Gastrointestinal Disorders (Q36426034) (← links)
- Lactulose Hydrogen Breath Test Result Is Associated with Age and Gender (Q36747480) (← links)
- Meta-analysis: antibiotic therapy for small intestinal bacterial overgrowth (Q37284278) (← links)
- Irritable bowel syndrome: emerging paradigm in pathophysiology (Q37629670) (← links)
- Gastrointestinal pH profile in subjects with irritable bowel syndrome (Q37647417) (← links)
- Diagnosis and management of IBS. (Q37796599) (← links)
- Methane on Breath Testing Is Associated with Constipation: A Systematic Review and Meta-analysis (Q37834415) (← links)
- Existing and emerging therapies for irritable bowel syndrome (Q37857849) (← links)
- Effects of Rifaximin Treatment and Retreatment in Nonconstipated IBS Subjects (Q37874146) (← links)
- The role of rifaximin therapy in patients with irritable bowel syndrome without constipation (Q37903847) (← links)
- The intestinal microbiota and chronic disorders of the gut (Q37918323) (← links)
- The efficacy and safety of rifaximin for the irritable bowel syndrome: a systematic review and meta-analysis (Q37951770) (← links)
- Review article: small intestinal bacterial overgrowth--prevalence, clinical features, current and developing diagnostic tests, and treatment (Q38129946) (← links)
- Microbiome, antibiotics and irritable bowel syndrome (Q38811947) (← links)
- Post-infectious IBS, tropical sprue and small intestinal bacterial overgrowth: the missing link (Q39022623) (← links)
- Hydrogen and Methane-Based Breath Testing in Gastrointestinal Disorders: The North American Consensus (Q42289564) (← links)
- Gut fermentation seems to promote decompression sickness in humans (Q46467997) (← links)
- A definitive blood test for post-infectious irritable bowel syndrome? (Q46484371) (← links)
- Irritable bowel syndrome in women (Q48325807) (← links)
- Gut Microbiota-Based Therapies for Irritable Bowel Syndrome (Q49985626) (← links)
- Antibiotic treatment of constipation-predominant irritable bowel syndrome (Q51726426) (← links)
- Effect of a Preparation of Four Probiotics on Symptoms of Patients with Irritable Bowel Syndrome: Association with Intestinal Bacterial Overgrowth. (Q52672657) (← links)
- Erosive esophagitis may be related to small intestinal bacterial overgrowth. (Q53384067) (← links)
- The role of small intestinal bacterial overgrowth in postgastrectomy patients. (Q53438153) (← links)
- Vagal dysfunction and small intestinal bacterial overgrowth: novel pathways to chronic inflammation in HIV. (Q54245944) (← links)
- Methanogens in Human Health and Disease (Q56048193) (← links)
- Methanobrevibacter smithii Is the Predominant Methanogen in Patients with Constipation-Predominant IBS and Methane on Breath (Q56873580) (← links)
- Short-course therapy for diarrhea-predominant irritable bowel syndrome: understanding the mechanism, impact on gut microbiota, and safety and tolerability of rifaximin (Q57070200) (← links)
- Double-Blind Placebo-Controlled Study of Rifaximin and Lactulose Hydrogen Breath Test in Gulf War Veterans with Irritable Bowel Syndrome (Q58108357) (← links)
- Does MHC heterozygosity influence microbiota form and function? (Q64914702) (← links)
- Diagnosis of Irritable Bowel Syndrome: What Are We Missing? (Q83378971) (← links)